Cost-effective and disposable label-free voltammetric immunosensor for sensitive detection of interleukin-6

Rocco Cancelliere1, Alessio Di Tinno2, Andrea Maria Di Lellis3

  • 1Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Roma, Italy.

Insights

Novel label-free immunosensors detect interleukin-6 (IL-6) in human serum rapidly and accurately. These biochar-based devices offer improved sensitivity and speed compared to traditional methods, enabling point-of-care diagnostics.

Area of Science:

  • Electrochemistry
  • Biosensors
  • Biomedical Diagnostics

Background:

  • Interleukin-6 (IL-6) is a crucial biomarker for monitoring diseases and treatment responses.
  • Current detection methods like ELISA are time-consuming and less sensitive.
  • Development of rapid, sensitive, and label-free detection methods for IL-6 is highly desirable.

Purpose of the Study:

  • To develop and characterize novel label-free voltammetric immunosensors for IL-6 detection.
  • To evaluate the analytical performance of these immunosensors in human serum and blood samples.
  • To compare the performance with existing commercial methods.

Main Methods:

  • Fabrication of screen-printed electrodes modified with biochar and IL-6 antibodies (mAb-IL-6 clone-5 and clone-7).
  • Electrochemical characterization using cyclic voltammetry (CV).
  • Sensing of IL-6 using square wave voltammetry (SWV).

Main Results:

  • The immunosensors demonstrated good analytical performance in human serum with wide linear ranges (26-138 pg/mL) and low limits of detection (4.8-5.4 pg/mL).
  • High selectivity for IL-6 over other cytokines (IL-1β, TNF-α).
  • The developed immunosensors showed superior sensitivity, reproducibility, and reduced detection time (30 min) compared to ELISA kits.

Conclusions:

  • The novel label-free voltammetric immunosensors provide a sensitive, rapid, and reproducible method for IL-6 detection.
  • These devices are suitable for direct application in diluted blood samples, indicating potential as point-of-care diagnostic tools.
  • The biochar-modified electrodes offer a cost-effective platform for developing advanced biosensors.